Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s stock price was up 0.2% during trading on Thursday . The stock traded as high as GBX 5,196 ($70.51) and last traded at GBX 5,162 ($70.05). Approximately 737,980 shares changed hands during trading, a decline of 83% from the average daily volume of 4,263,184 shares. The stock had previously closed at GBX 5,150 ($69.89).
Reckitt Benckiser Group Price Performance
The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46. The firm's 50 day moving average is GBX 4,910.18 and its 200 day moving average is GBX 5,010.90. The firm has a market cap of £34.70 billion, a P/E ratio of 23.27, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09.
Insider Buying and Selling
In other news, insider Kris Licht sold 3,799 shares of the company's stock in a transaction that occurred on Friday, March 21st. The shares were sold at an average price of GBX 5,177 ($70.25), for a total value of £196,674.23 ($266,894.06). 0.05% of the stock is currently owned by insiders.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
